These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29617712)

  • 1. Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
    Tao MH; Chen S; Freudenheim JL; Cauley JA; Johnson KC; Mai X; Sarto GE; Wakelee H; Boffetta P; Wactawski-Wende J
    Ann Oncol; 2018 Jun; 29(6):1476-1485. PubMed ID: 29617712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bisphosphonate use and risk of postmenopausal endometrial cancer.
    Newcomb PA; Passarelli MN; Phipps AI; Anderson GL; Wactawski-Wende J; Ho GY; O'Sullivan MJ; Chlebowski RT
    J Clin Oncol; 2015 Apr; 33(10):1186-90. PubMed ID: 25713431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.
    Passarelli MN; Newcomb PA; LaCroix AZ; Lane DS; Ho GY; Chlebowski RT
    J Bone Miner Res; 2013 Sep; 28(9):2043-8. PubMed ID: 23519920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
    Chlebowski RT; Chen Z; Cauley JA; Anderson G; Rodabough RJ; McTiernan A; Lane DS; Manson JE; Snetselaar L; Yasmeen S; O'Sullivan MJ; Safford M; Hendrix SL; Wallace RB
    J Clin Oncol; 2010 Aug; 28(22):3582-90. PubMed ID: 20567009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SA; Boudreau DM; Kooperberg C; Chlebowski RT; Gass M; Crandall CJ; Womack CR; Heckbert SR
    Menopause; 2016 Nov; 23(11):1168-1175. PubMed ID: 27433859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to oral bisphosphonates and risk of cancer.
    Cardwell CR; Abnet CC; Veal P; Hughes CM; Cantwell MM; Murray LJ
    Int J Cancer; 2012 Sep; 131(5):E717-25. PubMed ID: 22161552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women.
    Wotton CJ; Green J; Brown A; Armstrong MEG; Floud S; Beral V; Reeves GK;
    Bone; 2019 Jul; 124():69-74. PubMed ID: 30959190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
    Kremer R; Gagnon B; Meguerditchian AN; Nadeau L; Mayo N
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25278509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to oral bisphosphonates and risk of esophageal cancer.
    Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
    JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative.
    Wang A; Qin F; Hedlin H; Desai M; Chlebowski R; Gomez S; Eaton CB; Johnson KC; Qi L; Wactawski-Wende J; Womack C; Wakelee HA; Stefanick ML
    Int J Cancer; 2016 Nov; 139(10):2178-92. PubMed ID: 27439221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use and all-cancer survival: prospective results from the Women's Health Initiative.
    Wang A; Aragaki AK; Tang JY; Kurian AW; Manson JE; Chlebowski RT; Simon M; Desai P; Wassertheil-Smoller S; Liu S; Kritchevsky S; Wakelee HA; Stefanick ML
    Br J Cancer; 2016 Jun; 115(1):129-35. PubMed ID: 27280630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort.
    Wang A; Kubo J; Luo J; Desai M; Hedlin H; Henderson M; Chlebowski R; Tindle H; Chen C; Gomez S; Manson JE; Schwartz AG; Wactawski-Wende J; Cote M; Patel MI; Stefanick ML; Wakelee HA
    Ann Oncol; 2015 Jan; 26(1):221-230. PubMed ID: 25316260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative.
    Tao MH; Dai Q; Chen S; Freudenheim JL; Rohan T; Wakelee H; Datta M; Wactawski-Wende J
    Lung Cancer; 2017 Aug; 110():42-47. PubMed ID: 28676217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
    Oh YH; Yoon C; Park SM
    World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD and lung cancer incidence in the Women's Health Initiative Observational Study: A brief report.
    Nagasaka M; Lehman A; Chlebowski R; Haynes BM; Ho G; Patel M; Sakoda LC; Schwartz AG; Simon MS; Cote ML
    Lung Cancer; 2020 Mar; 141():78-81. PubMed ID: 31958598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.
    Liu Y; Zhao S; Chen W; Hu F; Zhu L; Zhang Q; Zhao Y
    Clin Breast Cancer; 2012 Aug; 12(4):276-81. PubMed ID: 22622199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.